A detailed history of Susquehanna International Group, LLP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 74,054 shares of GH stock, worth $3.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74,054
Previous 145,400 49.07%
Holding current value
$3.5 Million
Previous $4.2 Million 59.56%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$22.3 - $36.29 $1.65 Million - $2.69 Million
74,054 New
74,054 $1.7 Million
Q1 2024

May 07, 2024

BUY
$17.13 - $26.91 $1.18 Million - $1.85 Million
68,740 Added 44.39%
223,585 $4.61 Million
Q4 2023

Feb 14, 2024

SELL
$21.58 - $29.5 $821,895 - $1.12 Million
-38,086 Reduced 19.74%
154,845 $4.19 Million
Q3 2023

Nov 14, 2023

BUY
$25.8 - $39.97 $1.34 Million - $2.07 Million
51,782 Added 36.69%
192,931 $5.72 Million
Q2 2023

Aug 11, 2023

SELL
$20.94 - $38.01 $4.26 Million - $7.74 Million
-203,533 Reduced 59.05%
141,149 $5.05 Million
Q1 2023

May 16, 2023

BUY
$22.92 - $33.76 $4.48 Million - $6.6 Million
195,496 Added 131.04%
344,682 $8.08 Million
Q4 2022

Feb 14, 2023

BUY
$25.44 - $59.78 $2.66 Million - $6.26 Million
104,660 Added 235.05%
149,186 $4.06 Million
Q3 2022

Nov 14, 2022

SELL
$43.66 - $61.0 $3.77 Million - $5.26 Million
-86,270 Reduced 65.96%
44,526 $2.4 Million
Q2 2022

Aug 15, 2022

BUY
$28.82 - $77.35 $2.67 Million - $7.16 Million
92,569 Added 242.16%
130,796 $5.28 Million
Q1 2022

May 16, 2022

SELL
$48.25 - $100.49 $347,786 - $724,331
-7,208 Reduced 15.86%
38,227 $2.53 Million
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $3.79 Million - $5.15 Million
42,754 Added 1594.7%
45,435 $4.54 Million
Q3 2021

Nov 15, 2021

BUY
$98.77 - $132.17 $90,868 - $121,596
920 Added 52.24%
2,681 $335,000
Q1 2021

May 17, 2021

SELL
$127.04 - $179.1 $448,451 - $632,223
-3,530 Reduced 66.72%
1,761 $269,000
Q4 2020

Feb 16, 2021

BUY
$99.96 - $135.93 $304,478 - $414,042
3,046 Added 135.68%
5,291 $682,000
Q3 2020

Nov 16, 2020

SELL
$80.32 - $111.8 $15.1 Million - $21 Million
-188,270 Reduced 98.82%
2,245 $251,000
Q2 2020

Aug 14, 2020

BUY
$60.49 - $97.5 $5.95 Million - $9.6 Million
98,419 Added 106.87%
190,515 $15.5 Million
Q1 2020

May 15, 2020

SELL
$59.04 - $88.81 $4.8 Million - $7.22 Million
-81,310 Reduced 46.89%
92,096 $6.41 Million
Q4 2019

Feb 14, 2020

SELL
$59.49 - $82.78 $2.92 Million - $4.06 Million
-49,106 Reduced 22.07%
173,406 $13.6 Million
Q3 2019

Nov 14, 2019

BUY
$62.59 - $110.3 $8.76 Million - $15.4 Million
139,931 Added 169.45%
222,512 $14.2 Million
Q2 2019

Aug 16, 2019

BUY
$63.94 - $91.11 $2.46 Million - $3.5 Million
38,409 Added 86.95%
82,581 $7.13 Million
Q2 2019

Aug 14, 2019

BUY
$63.94 - $91.11 $181,397 - $258,479
2,837 Added 6.86%
44,172 $3.81 Million
Q1 2019

May 15, 2019

BUY
$34.3 - $97.98 $1.42 Million - $4.05 Million
41,335 New
41,335 $3.17 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.83B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.